Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.34 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.32 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.32 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23430236 | 0.82 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL36366 | 0.79 | HDAC3 (0.33) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL10362582 | 0.79 | NPSR1 (0.50) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL1995274 | 0.79 | HPGD (0.38) | TBXAS1ACMSDNPSR1 | |
| SCHEMBL1512895 | 0.78 | GRIA1 (0.36) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL9623341 | 0.78 | PTGS1 (0.36) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL6277305 | 0.77 | HDAC3 (0.32) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL1469166 | 0.77 | HDAC3 (0.32) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL2919621 | 0.76 | HDAC4 (0.39) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL10171591 | 0.74 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2106855-B1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL IND LTD (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-7700789-B2 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-20 | — | — | US | disclosed |
| EP-1632291-B1 | HETEROGENEOUS CATALYST AND PROCESS FOR PRODUCING OXIRANE COMPOUND WITH THE CATALYST | NISSAN CHEMICAL IND LTD (JP) | 2009-12-16 | — | — | EP | disclosed |
| EP-2106855-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | Nissan Chemical Industries, Ltd. (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090082583-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20070093667-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1632291-A1 | HETEROGENEOUS CATALYST AND PROCESS FOR PRODUCING OXIRANE COMPOUND WITH THE CATALYST | Nissan Chemical Industries, Ltd. (JP) | 2006-03-08 | — | — | EP | disclosed |
| CN-1177782-C | Reactive coalescents | ��������ķ������ | 2004-12-01 | — | — | CN | disclosed |
| US-6048664-A | Energy-sensitive resist material and a process for device fabrication using an energy-sensitive resist material | LUCENT TECHNOLOGIES, INC. (US) | 2000-04-11 | — | — | US | disclosed |
| CN-1195656-A | Reactive coalescents | ROHM & HAAS (US) | 1998-10-14 | — | — | CN | disclosed |
| US-4855488-A | Process for the preparation of dicyclopentenol esters | HUELS AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| EP-0300162-A2 | Method for the production of dicyclopentenol esters | HÜLS AKTIENGESELLSCHAFT (DE) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093667-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | OXGR1, OXER1, OGFOD1 | HDAC4 1656/4885HDAC2 215/4885HDAC8 1318/4885 |
| US-20090082583-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | OXGR1, OGFOD1, OGDH | HDAC4 1259/4885HDAC2 167/4885HDAC8 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.